The mixed reactions toward the Toxic Substances Control Act reform bill introduced by Reps. Henry Waxman, D-Calif., and Bobby Rush, D-Ill., could minimize the bill's chances to be passed this year. Despite assertions that the bill will reduce illnesses from toxins, the measure's strict reporting requirements create a nearly impossible burden on industry, said Cal Dooley, president and CEO of the American Chemistry Council, adding that the bill will stifle competition and hinder job creation and product development. "You don't have to be a rocket scientist or a chemical engineer to understand the impact this policy will have on innovation," Dooley said.

Related Summaries